Back to company

SPECIALLÆGE I ALMEN MEDICIN AGATA BRYLSKA ApS: Financial statements 2024

CVR: 33055846

SPECIALLÆGE I ALMEN MEDICIN AGATA BRYLSKA ApS (CVR 33055846) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,241,711 and a net result of DKK 448,486 compared with DKK 409,877 the year before. That is a decrease of 5% compared with the year before. Equity amounted to DKK 528,486. The solvency ratio was 52.2%. The company had 4 employees in the financial year.

Gross Profit
2,241,711 kr.
Profit/Loss
448,486 kr.
Equity
528,486 kr.
Total Assets
1,011,830 kr.
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-2.2 mio.448 t.528 t.4
2023-2.4 mio.410 t.490 t.4
2022-2.2 mio.350 t.430 t.3
2021-2.3 mio.610 t.690 t.3
2020-2.1 mio.424 t.516 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is SPECIALLÆGE I ALMEN MEDICIN AGATA BRYLSKA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About SPECIALLÆGE I ALMEN MEDICIN AGATA BRYLSKA ApS

SPECIALLÆGE I ALMEN MEDICIN AGATA BRYLSKA ApS is a Danish company of the type Anpartsselskab based in Aabenraa, founded in 2010. The company is registered under the industry Speciallægers aktiviteter. The management consists of Agata Brylska. The company is owned by Agata Brylska. The company has 4 employees. In 2025, the company reported a gross profit of DKK 2,333,145 and a net result of DKK 380,001 compared with DKK 448,486 the year before. Equity amounted to DKK 460,000.